Treatment of infants with RSV infection: A retrospective analysis of the season 1998/99;Behandlung von kindern mit RSV-infektionen: Eine retrospektive analyse der saison 1998/99

Klinische Padiatrie

Volumn 214, Issue 1, 2002, Pages 37-40

  Schauer, Uwe ^a   Rieger, C H L ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Epidemiology; Palivizumab; Prematurity; Respiratory syncytial virus

Indexed keywords

MONOCLONAL ANTIBODY; PALIVIZUMAB;

ARTICLE; CHILD HOSPITALIZATION; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; INFANT; INFECTION PREVENTION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; NEWBORN; NORTH AMERICA; PATIENT SELECTION; PRACTICE GUIDELINE; PREMATURITY; PRESCHOOL CHILD; PROPHYLAXIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; UNITED KINGDOM;

ANTIBODIES, MONOCLONAL; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; LENGTH OF STAY; MALE; OXYGEN INHALATION THERAPY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036148283     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-19863     Document Type: Article

References (17)

1. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
2. Dexamethasone in bronchiolitis: A randomised controlled trial
3. Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis
4. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study
5. Treatment of respiratory syncytial virus bronchiolitis: 1995 Poll of members of the European Society for Paediatric Infectious Diseases
6. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children
7. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
8. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis
9. The fluctuating pattern of various genome types of respiratory syncytial virus in Copenhagen and some other locations in Denmark
10. Nosokomiale infektionen mit dem respiratory syncytial virus in der pädiatrie - Vorkommen, primärprävention, krankenhaushygienischer standard
11. Rehospitalization for respiratory syncytial virus among premature infants
12. Prophylaxe der Respiratory Syncytial Virus (RSV)-infektion bei frühgeborenen mit/ohne bronchopulmonaler dysplasie: Hyperimmunglobulin (RSV-IGIV) und palivizumab (MEDI-493)
13. Respiratory syncytial virus infection
14. Respiratory syncytial virus infections within families
15. Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IGIV
16. Stellungnahme der deutschen gesellschaft für pädiatrische infektiologie zur prophylaxe von RSV-erkrankungen durch immunglobuline